(Q38116773)

29 August 2017

title

A systematic review of health-related quality of life instruments in patients with cancer cachexia (English)

1 reference

29 August 2017

1 reference

4

Deborah Fitzsimmons

0 references

Sally J Wheelwright

object named as

Sally Wheelwright

1

0 references

author name string

Anne-Sophie Darlington

2

1 reference

29 August 2017

Jane B Hopkinson

3

1 reference

29 August 2017

Alice White

5

1 reference

29 August 2017

Colin D Johnson

6

1 reference

29 August 2017

language of work or name

1 reference

25 June 2013

1 reference

Supportive Care in Cancer

29 August 2017

published in

1 reference

29 August 2017

volume

21

1 reference

29 August 2017

issue

9

1 reference

29 August 2017

page(s)

2625-2636

1 reference

Definition and classification of cancer cachexia: an international consensus

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1881-9

ABC of palliative care. Anorexia, cachexia, and nutrition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1881-9

Cachexia in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1881-9

A questionnaire study of the approach to the anorexia-cachexia syndrome in patients with cancer by staff in a district general hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1881-9

Re-validation and shortening of the Functional Assessment of Anorexia/Cachexia Therapy (FAACT) questionnaire

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1881-9

Loss of appetite: a poetic exploration of cancer patients' and their carers' experiences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1881-9

A qualitative analysis of the nutritional requirements of palliative care patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1881-9

Family beliefs regarding the nutritional care of a terminally ill relative: a qualitative study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1881-9

Helping patients with advanced cancer live with concerns about eating: a challenge for palliative care professionals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1881-9

Fighting a losing battle: eating-related distress of men with advanced cancer and their female partners. A mixed-methods study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1881-9

'The reflections you get': an exploration of body image and cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1881-9

The nature of terminal malignant bowel obstruction and its impact on patients with advanced cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1881-9

Disruptions in the organization of meal preparation and consumption among older cancer patients and their family caregivers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1881-9

Exploring the experience of weight loss in people with advanced cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1881-9

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1881-9

Consensus on cachexia definitions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1881-9

Rating the methodological quality in systematic reviews of studies on measurement properties: a scoring system for the COSMIN checklist

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1881-9

Beyond the development of health-related quality-of-life (HRQOL) measures: a checklist for evaluating HRQOL outcomes in cancer clinical trials--does HRQOL evaluation in prostate cancer research inform clinical decision making?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1881-9

Malnutrition and food intake in relation to quality of life in head and neck cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1881-9

Phase II trial of mirtazapine for cancer-related cachexia and anorexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1881-9

Importance of early nutritional screening in patients with gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1881-9

Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the C

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1881-9

Mode of questionnaire administration can have serious effects on data quality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1881-9

Quality, interpretation and presentation of European Organisation for Research and Treatment of Cancer quality of life questionnaire core 30 data in randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1881-9

Quality of life in pulmonary surgery: choosing, using, and developing assessment tools

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1881-9

How can quality of life researchers make their work more useful to health workers and their patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1881-9

Physiological basis of fatigue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1881-9

Cancer: disease and nutrition are key determinants of patients' quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1881-9

The emotional aspects of cancer anorexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1881-9

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1881-9

EuroQol--a new facility for the measurement of health-related quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1881-9

A randomized, double-blind, placebo-controlled trial of a beta-hydroxyl beta-methyl butyrate, glutamine, and arginine mixture for the treatment of cancer cachexia (RTOG 0122)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1881-9

Supportive use of megestrol acetate in patients with head and neck cancer during radio(chemo)therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1881-9

Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1881-9

An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1881-9

Effects of recombinant erythropoietin in palliative treatment of unselected cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1881-9

Insulin treatment in cancer cachexia: effects on survival, metabolism, and physical functioning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1881-9

Effects by daily long term provision of ghrelin to unselected weight-losing cancer patients: a randomized double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1881-9

A prospective randomized study of megestrol acetate and ibuprofen in gastrointestinal cancer patients with weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1881-9

Treatment of cancer-related anorexia with olanzapine and megestrol acetate: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1881-9

Cysteine-rich protein reverses weight loss in lung cancer patients receiving chemotherapy or radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1881-9

Megestrol acetate in advanced, progressive, hormone-insensitive cancer. Effects on the quality of life: a placebo-controlled, randomised, multicentre trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1881-9

A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and/or poor performance non-small cell lung cancer patients (N01C9).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1881-9

Simple nutritional intervention in patients with advanced cancers of the gastrointestinal tract, non-small cell lung cancers or mesothelioma and weight loss receiving chemotherapy: a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1881-9

Effects of a high-fat diet on body composition in cancer patients receiving chemotherapy: a randomized controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1881-9

Weight stabilisation is associated with improved survival duration and quality of life in unresectable pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1881-9

Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1881-9

Early supplementation of parenteral nutrition is capable of improving quality of life, chemotherapy-related toxicity and body composition in patients with advanced colorectal carcinoma undergoing palliative treatment: results from a prospective, ran

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1881-9

Reversal of cancer-related wasting using oral supplementation with a combination of beta-hydroxy-beta-methylbutyrate, arginine, and glutamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1881-9

Long-term oral branched chain amino acids in patients undergoing chemoembolization for hepatocellular carcinoma: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1881-9

Perioperative enteral nutrition and quality of life of severely malnourished head and neck cancer patients: a randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1881-9

Marine phospholipids--a promising new dietary approach to tumor-associated weight loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1881-9

Nutrition intervention using an eicosapentaenoic acid (EPA)-containing supplement in patients with advanced colorectal cancer. Effects on nutritional and inflammatory status: a phase II trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1881-9

Phase II study of high-dose fish oil capsules for patients with cancer-related cachexia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1881-9

Megestrol acetate in cancer patients with anorexia and weight loss. A Hellenic Co-operative Oncology Group (HeCOG) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1881-9

Phase II nonrandomized study of the efficacy and safety of COX-2 inhibitor celecoxib on patients with cancer cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1881-9

Phase II study of the novel peptide-nucleic acid OHR118 in the management of cancer-related anorexia/cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1881-9

Quality of life and length of survival in advanced cancer patients on home parenteral nutrition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1881-9

Nutrition intervention improves outcomes in patients with cancer cachexia receiving chemotherapy--a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1881-9

Nutritional status of patients with locally advanced pancreatic cancer: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1881-9

Daily physical-rest activities in relation to nutritional state, metabolism, and quality of life in cancer patients with progressive cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1881-9

A prospective study on malnutrition and quality of life in patients with head and neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1881-9

Objective physical activity and self-reported quality of life in patients receiving palliative chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1881-9

Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1881-9

Determinants of hand grip strength, knee extension strength and functional status in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1881-9

Defining cancer cachexia in head and neck squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1881-9

Prevalence and influence of malnutrition on quality of life and performance status in patients with locally advanced head and neck cancer before treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1881-9

Systemic inflammation, cardiorespiratory fitness, and quality of life in patients with advanced non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1881-9

Serum concentrations of TNF-alpha as a surrogate marker for malnutrition and worse quality of life in patients with gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1881-9

Impact of weight loss, appetite, and the inflammatory response on quality of life in gastrointestinal cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1881-9

The interrelationship of weight loss, dietary intake, and quality of life in ambulatory patients with cancer of the lung, breast, and ovary

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1881-9

A prospective study of the impact of weight loss and the systemic inflammatory response on quality of life in patients with inoperable non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1881-9

Quality of life as predictor of weight loss in patients with head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1881-9

The path from oral nutrition to home parenteral nutrition: a qualitative interview study of the experiences of advanced cancer patients and their families

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1881-9

Body composition in patients with non−small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1881-9

Chemosensory Dysfunction Is a Primary Factor in the Evolution of Declining Nutritional Status and Quality of Life in Patients With Advanced Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1881-9

The influence of early supplementation of parenteral nutrition on quality of life and body composition in patients with advanced cancer

21 January 2018

1 reference

12 December 2020

The Functional Assessment of Anorexia/Cachexia Therapy (FAACT) Appetite Scale in veteran cancer patients

1 reference

12 December 2020

Effectiveness of megestrol acetate in patients with advanced cancer: a randomized, double-blind, crossover study

1 reference

12 December 2020

The experience of cancer cachexia: A qualitative study of advanced cancer patients and their family members

1 reference

12 December 2020

Desnutrição e Qualidade de Vida em Doentes com Cancro do Pulmão Não Pequenas Células

1 reference

12 December 2020

Impact of nutritional status on the quality of life of advanced cancer patients in hospice home care.

1 reference

12 December 2020

Quality of life research in cancer clinical trials: a need for common rules and language

1 reference

12 December 2020

A phase II study with antioxidants, both in the diet and supplemented, pharmaconutritional support, progestagen, and anti-cyclooxygenase-2 showing efficacy and safety in patients with cancer-related anorexia/cachexia and oxidative stress

1 reference

12 December 2020

Anorexia in the Terminally Ill Cancer Patient: The Emotional Impact on the Patient and the Family

1 reference

12 December 2020

The Functional Assessment of Cancer Therapy scale: development and validation of the general measure

1 reference

12 December 2020

A randomized study of nutritional support in patients with colorectal and gastric cancer

1 reference

12 December 2020

Effect of dietary counseling on food intake, body weight, response rate, survival, and quality of life in cancer patients undergoing chemotherapy: a prospective, randomized study

1 reference

12 December 2020

Relationship between nutritional status and quality of life in patients with cancer

1 reference

12 December 2020

Effects of medroxyprogesterone acetate on appetite, weight, and quality of life in advanced-stage non-hormone-sensitive cancer: a placebo-controlled multicenter study

1 reference

12 December 2020

Anticachectic efficacy of megestrol acetate at different doses and versus placebo in patients with neoplastic cachexia

1 reference

12 December 2020

Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis

1 reference

12 December 2020

Nutritional behaviour and quality of life during oncological polychemotherapy: results of a prospective study on the efficacy of oral nutrition therapy in patients with acute leukaemia

1 reference

12 December 2020

1 reference

12 December 2020

The relevance of weight loss for survival and quality of life in patients with advanced gastrointestinal cancer treated with palliative chemotherapy.

1 reference

12 December 2020

A multicenter, phase II study of infliximab plus gemcitabine in pancreatic cancer cachexia

1 reference

12 December 2020

Potential usefulness of an EPA-enriched nutritional supplement on chemotherapy tolerability in cancer patients without overt malnutrition.

1 reference

12 December 2020

10.1007/S00520-013-1881-9

Identifiers

DOI

1 reference

29 August 2017

1 reference